VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,992 | -10.8% | 222,680 | -0.2% | 3.94% | -7.0% |
| Q2 2023 | $6,717 | -7.7% | 223,105 | -0.8% | 4.23% | -15.3% |
| Q1 2023 | $7,274 | +12.9% | 224,878 | 0.0% | 4.99% | +3.1% |
| Q4 2022 | $6,445 | -99.9% | 224,878 | +1.2% | 4.84% | +28.9% |
| Q3 2022 | $5,357,000 | -13.1% | 222,115 | -1.4% | 3.76% | -8.1% |
| Q2 2022 | $6,167,000 | -28.6% | 225,265 | 0.0% | 4.09% | -10.5% |
| Q1 2022 | $8,638,000 | +22.8% | 225,265 | +2.6% | 4.57% | +30.7% |
| Q4 2021 | $7,033,000 | +40.6% | 219,580 | +29.3% | 3.50% | +32.2% |
| Q3 2021 | $5,003,000 | -13.0% | 169,785 | +0.3% | 2.64% | -14.7% |
| Q2 2021 | $5,750,000 | +2.2% | 169,225 | -2.3% | 3.10% | -7.4% |
| Q1 2021 | $5,628,000 | -9.2% | 173,174 | +0.6% | 3.35% | -18.4% |
| Q4 2020 | $6,199,000 | -7.6% | 172,115 | +0.5% | 4.10% | -21.9% |
| Q3 2020 | $6,708,000 | +6.7% | 171,320 | -0.0% | 5.26% | +7.1% |
| Q2 2020 | $6,286,000 | +60.2% | 171,400 | +0.6% | 4.91% | +32.6% |
| Q1 2020 | $3,924,000 | +20.4% | 170,350 | +53.0% | 3.70% | +73.8% |
| Q4 2019 | $3,259,000 | +9.3% | 111,315 | -0.3% | 2.13% | +2.2% |
| Q3 2019 | $2,981,000 | +5.0% | 111,615 | +0.5% | 2.08% | +6.6% |
| Q2 2019 | $2,839,000 | +14.2% | 111,085 | +0.1% | 1.96% | +10.4% |
| Q1 2019 | $2,487,000 | +6.2% | 110,950 | -0.1% | 1.77% | -2.7% |
| Q4 2018 | $2,341,000 | +11.7% | 111,020 | -1.9% | 1.82% | +28.6% |
| Q3 2018 | $2,095,000 | -17.0% | 113,170 | 0.0% | 1.42% | -23.8% |
| Q2 2018 | $2,524,000 | +1.5% | 113,170 | 0.0% | 1.86% | +3.2% |
| Q1 2018 | $2,487,000 | -5.4% | 113,170 | 0.0% | 1.80% | -5.4% |
| Q4 2017 | $2,630,000 | +0.8% | 113,170 | -0.4% | 1.90% | -4.0% |
| Q3 2017 | $2,609,000 | +11.6% | 113,640 | +7.3% | 1.98% | +15.4% |
| Q2 2017 | $2,338,000 | -3.2% | 105,900 | 0.0% | 1.72% | -5.4% |
| Q1 2017 | $2,415,000 | +9.1% | 105,900 | +0.0% | 1.82% | +2.1% |
| Q4 2016 | $2,214,000 | -22.0% | 105,865 | -1.5% | 1.78% | -21.8% |
| Q3 2016 | $2,840,000 | -4.6% | 107,475 | 0.0% | 2.28% | -10.1% |
| Q2 2016 | $2,978,000 | – | 107,475 | – | 2.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |